Entera Bio Ltd. (FRA:5DT)

Entera Bio Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	57	75	16	20	71	16
Market Cap Growth	-32.57%	382.21%	-20.52%	-72.38%	339.48%	-30.05%
Enterprise Value	50	69	9	6	47	11
Last Close Price	1.17	2.02	0.48	0.60	2.56	-
PS Ratio	541.40	431.41	-	156.95	141.91	54.33
PB Ratio	4.41	9.66	1.67	1.79	3.59	2.64
P/TBV Ratio	4.41	9.66	1.67	1.79	3.59	2.64
EV/Sales Ratio	-	394.91	-	51.05	94.51	35.56
Debt / Equity Ratio	0.01	0.03	0.04	0.01	0.01	0.06
Net Debt / Equity Ratio	-0.55	-1.04	-1.02	-1.04	-1.09	-1.09
Net Debt / EBITDA Ratio	0.78	0.88	1.20	0.91	2.02	0.74
Net Debt / FCF Ratio	1.18	1.23	1.45	0.97	2.71	0.77
Asset Turnover	0.01	0.02	-	0.01	0.03	0.03
Quick Ratio	5.46	7.47	10.10	9.36	7.93	4.81
Current Ratio	10.83	7.63	10.32	9.58	8.01	4.95
Return on Equity (ROE)	-99.43%	-103.34%	-80.30%	-76.17%	-81.04%	-115.46%
Return on Assets (ROA)	-53.80%	-56.64%	-44.65%	-43.06%	-42.77%	-52.83%
Return on Capital Employed (ROCE)	-68.40%	-116.70%	-83.30%	-114.30%	-53.50%	-141.70%
Earnings Yield	-16.06%	-12.22%	-51.42%	-62.15%	-15.04%	-56.56%
FCF Yield	-10.56%	-8.73%	-42.38%	-59.65%	-11.21%	-53.50%
Buyback Yield / Dilution	-25.17%	-29.79%	-0.69%	-10.23%	-41.90%	-51.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.